US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vanguard Total World Stock ETF

138.08

+0.43000.31%

Post-market: 138.200.1200+0.09%19:57 EDT

Volume:7.24M

Turnover:996.80M

Market Cap:55.50B

PE:- -

High:138.30

Open:137.30

Low:136.95

Close:137.65

52wk High:139.80

52wk Low:100.89

Shares:401.94M

Float Shares:401.94M

Volume Ratio:1.96

T/O Rate:1.80%

Dividend:2.34

Dividend Rate:1.69%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

ETF & Stock Investment+0.44%

Fractional Shares+0.44%

Capital Flow

Inflow:

Outflow:

News

Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden

Adagio Medical Reports Promising Results from FULCRUM-VT Study

Adagio Medical announces preliminary acute results from FULCRUM-VT study

Field Medical First-in-Human 6-Month Data Selected for Late-Breaking Clinical Trial at VT Symposium 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VT\",,,,,undefined,":{"symbol":"VT","market":"US","secType":"STK","nameCN":"Vanguard Total World Stock ETF","latestPrice":138.08,"timestamp":1760731200000,"preClose":137.65,"halted":0,"volume":7243881,"hourTrading":{"tag":"盘后","latestPrice":138.2,"preClose":138.08,"latestTime":"19:57 EDT","volume":248935,"amount":34382587.5963,"timestamp":1760745430953},"delay":0,"floatShares":401942794,"shares":401942794,"eps":0,"marketStatus":"Market Closed","change":0.43,"latestTime":"10-17 16:00:00 EDT","open":137.3,"high":138.295,"low":136.95,"amount":996801851.0800501,"amplitude":0.009771,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":137.65,"sharesOutstanding":401942794,"nav":137.52,"aum":55275173030.88,"dividendRate":0.016947,"bidAskSpread":0.000094,"preHourTrading":{"tag":"盘前","latestPrice":137.63,"preClose":137.65,"latestTime":"09:25 EDT","volume":3592,"amount":492879.44096,"timestamp":1760707556803},"postHourTrading":{"tag":"盘后","latestPrice":138.2,"preClose":138.08,"latestTime":"19:57 EDT","volume":248935,"amount":34382587.5963,"timestamp":1760745430953},"volumeRatio":1.9607620651909488,"impliedVol":0.1897,"impliedVolPercentile":0.868},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VT\",,,,,undefined,":{"symbol":"VT","floatShares":401942794,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.9607620651909488,"shares":401942794,"dividePrice":2.3401,"high":138.295,"amplitude":0.009771,"preClose":137.65,"low":136.95,"week52Low":100.89,"pbRate":"--","week52High":139.799,"institutionHeld":0,"latestPrice":138.08,"eps":0,"divideRate":0.016947,"volume":7243881,"delay":0,"ttmEps":0,"open":137.3,"prevYearClose":117.48,"prevWeekClose":135.16,"prevMonthClose":137.8,"prevQuarterClose":137.8,"fiveDayClose":135.16,"twentyDayClose":137.47,"sixtyDayClose":131.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VT\",params:#limit:5,,,undefined,":[{"date":"2025-09-19","symbol":"VT","amount":0.4781,"announcedDate":"2025-09-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-19","defaultRemindTime":1758288600000,"name":"世界全股市ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-19","currency":"USD","dateTimestamp":1758254400000,"payDate":"2025-09-23"},{"date":"2025-06-20","symbol":"VT","amount":0.5947,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-20","defaultRemindTime":1750426200000,"name":"世界全股市ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-24","payableDate":"2025-06-20","currency":"USD","dateTimestamp":1750392000000,"payDate":"2025-06-24"},{"date":"2025-03-21","symbol":"VT","amount":0.3852,"announcedDate":"2025-03-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"世界全股市ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-25","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-25"},{"date":"2024-12-20","symbol":"VT","amount":0.8774,"announcedDate":"2024-12-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"世界全股市ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-09-20","symbol":"VT","amount":0.4174,"announcedDate":"2024-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-20","defaultRemindTime":1726839000000,"name":"世界全股市ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-24","payableDate":"2024-09-20","currency":"USD","dateTimestamp":1726804800000,"payDate":"2024-09-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VT\",market:\"US\",,,undefined,":[{"executeDate":"2015-12-21","recordDate":"2015-12-23","paymentDate":"2015-12-28","value":0.368,"currency":"USD"},{"executeDate":"2016-03-15","recordDate":"2016-03-17","paymentDate":"2016-03-21","value":0.222,"currency":"USD"},{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-20","value":0.466,"currency":"USD"},{"executeDate":"2016-09-13","recordDate":"2016-09-15","paymentDate":"2016-09-19","value":0.311,"currency":"USD"},{"executeDate":"2016-12-20","recordDate":"2016-12-22","paymentDate":"2016-12-27","value":0.457,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2574107004","title":"Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden","url":"https://stock-news.laohu8.com/highlight/detail?id=2574107004","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574107004?lang=en_us&edition=fundamental","pubTime":"2025-10-11 04:35","pubTimestamp":1760128500,"startTime":"0","endTime":"0","summary":"Findings presented at the International VT Symposium and published simultaneously in Circulation. CARDIFF-BY-THE-SEA, Calif. and PHILADELPHIA, Oct. 11, 2025 /PRNewswire/ -- Field Medical, Inc. today announced that Circulation has published six-month outcomes from the Ventricular Catheter Ablation Study , the first-in-human evaluation of its FieldForce Ablation System for ventricular tachycardia . Results were also presented as a late-breaking trial at the 20th Annual International Symposium on Ventricular Arrhythmias .The FieldForce Ablation System by Field Medical: This next-generation PFA system is designed for transmural lesion creation, offering a novel approach to VT ablation.Results at Six MonthsVCAS is a prospective, multicenter feasibility trial evaluating the safety and performance of the FieldForce Ablation System in patients with VT. Unlike conventional approaches, the system delivers a proprietary high-voltage, short-pulse waveform designed to penetrate dense scar tissue wh","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2792975/Field_Medical_FieldForce__Ablation_System_Next_generation_PFA.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2792975/Field_Medical_FieldForce__Ablation_System_Next_generation_PFA.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/circulation-publishes-6-month-outcomes-from-first-in-human-vcas-trial-of-fieldforce-pulsed-field-ablation-system-82-freedom-from-vtvf-recurrence-and-98-reduction-in-burden-302581164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","BK4585","IE00B3T34201.USD","LU0321505439.SGD","BK4158","LU0321505868.SGD","VT","LU0225771236.USD","LU0306806265.USD","LU0306807586.USD","TAP.AU","LU0225284248.USD","TAP","BK4588"],"gpt_icon":0},{"id":"2574102428","title":"Adagio Medical Reports Promising Results from FULCRUM-VT Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2574102428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574102428?lang=en_us&edition=fundamental","pubTime":"2025-10-11 03:57","pubTimestamp":1760126253,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Adagio Medical Holdings ( ($ADGM) ). On October 10, 2025, Adagio Medical Holdings announced preliminary acute s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adagio-medical-reports-promising-results-from-fulcrum-vt-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adagio-medical-reports-promising-results-from-fulcrum-vt-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VT","BK4588","BK4585"],"gpt_icon":0},{"id":"2574110244","title":"Adagio Medical announces preliminary acute results from FULCRUM-VT study","url":"https://stock-news.laohu8.com/highlight/detail?id=2574110244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574110244?lang=en_us&edition=fundamental","pubTime":"2025-10-11 03:45","pubTimestamp":1760125516,"startTime":"0","endTime":"0","summary":"Adagio Medical (ADGM) announced preliminary acute safety and efficacy results from Adagio’s FULCRUM-VT Study evaluating Ultralow Temperature Cryoab...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adagio-medical-announces-preliminary-acute-results-from-fulcrum-vt-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adagio-medical-announces-preliminary-acute-results-from-fulcrum-vt-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","VT","BK4588","ADGM","BK4082"],"gpt_icon":0},{"id":"2574150401","title":"Field Medical First-in-Human 6-Month Data Selected for Late-Breaking Clinical Trial at VT Symposium 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2574150401","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574150401?lang=en_us&edition=fundamental","pubTime":"2025-10-09 20:33","pubTimestamp":1760013180,"startTime":"0","endTime":"0","summary":"Three sessions feature new outcomes, a live case, and preclinical research with the FieldForce Ablation System.  CARDIFF-BY-THE-SEA, Calif., and PHILADELPHIA, Oct. 9, 2025 /PRNewswire/ --Field Medical, Inc., a leader in pulsed field ablation  technology for ventricular tachycardia , today announced its participation at the 20th Annual International Symposium on Ventricular Arrhythmias, taking place Oct. 10 –11 in Philadelphia.Field Medical: Engineered to reach the epicardium from the endocardium, the FieldForce Ablation System catheter is designed to enable focal pulsed field ablation for full-thickness, transmural lesions.Field Medical will be featured across three sessions, including first-in-human six-month outcomes from itsFieldForce Ablation System, the first focal contact-force PFA platform designed for VT, a pre-recorded live VT case and translational preclinical research.","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2792233/Field_Medical_FieldForce_Ablation_System_PFA_Catheter.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2792233/Field_Medical_FieldForce_Ablation_System_PFA_Catheter.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/field-medical-first-in-human-6-month-data-selected-for-late-breaking-clinical-trial-at-vt-symposium-2025-302579332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VT","LU1066053197.SGD","LU1066051498.USD","LU1066051811.HKD","BK4585","LU1066051225.USD","BK4588","CTO.AU","CTO","BK7104","BK4160"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VT\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ETF & Stock Investment","bkCode":"BK4585","id":"package_us_concept_etf&gpdt","changeRate":0.004385},{"market":"US","name":"Fractional Shares","bkCode":"BK4588","id":"package_us_concept_sg","changeRate":0.004382}]}}